Abbott Laboratories (ABT) Tops Q2 EPS by 2c; Affirms FY13 Outlook
Abbott Laboratories (NYSE: ABT) reported Q2 EPS of $0.46, $0.02 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
